Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy
- PMID: 18573654
- DOI: 10.1016/j.ejca.2008.05.004
Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy
Abstract
Aim: The aim was to study the effects of the introduction of TME surgery and pre-operative radiotherapy on overall survival (OS) by comparing patients treated in the period before (1990-1995), during (1996-1999) and after (2000-2002) the TME trial.
Patients and methods: Patients diagnosed with rectal carcinoma in the region of Comprehensive Cancer Centres South and West were used (n=3179).
Results: Five-year OS was, respectively, 56%, 62% and 65% in the pre-trial, trial and post-trial periods (p<0.001). Pre-operative RT was increasingly used over time and significantly related to OS in the post-trial period (p=0.002), but not in the pre-trial and trial periods.
Conclusions: Population-based OS improved markedly since the introduction of TME surgery. With standardised TME surgery, pre-operative RT improved OS, whereas withholding pre-operative RT was associated with a poorer prognosis. The present study supports that pre-operative RT was correctly introduced as a standard treatment before TME surgery in our national guideline.
Similar articles
-
Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.Eur J Cancer. 2007 Oct;43(15):2295-300. doi: 10.1016/j.ejca.2007.07.009. Epub 2007 Aug 20. Eur J Cancer. 2007. PMID: 17709242
-
Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.Br J Surg. 2002 Sep;89(9):1142-9. doi: 10.1046/j.1365-2168.2002.02196.x. Br J Surg. 2002. PMID: 12190680 Clinical Trial.
-
Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.Eur J Surg Oncol. 2007 Sep;33(7):862-7. doi: 10.1016/j.ejso.2006.12.005. Epub 2007 Jan 24. Eur J Surg Oncol. 2007. PMID: 17257804
-
Pre-operative combined modality therapy in the management of locally advanced rectal cancer.Eur J Surg Oncol. 2006 Apr;32(3):259-68. doi: 10.1016/j.ejso.2005.12.002. Epub 2006 Jan 27. Eur J Surg Oncol. 2006. PMID: 16443345 Review.
-
European trials with total mesorectal excision.Semin Surg Oncol. 2000 Dec;19(4):350-7. doi: 10.1002/ssu.5. Semin Surg Oncol. 2000. PMID: 11241917 Review.
Cited by
-
Intraoperative adverse events as a risk factor for local recurrence of rectal cancer after resection surgery.Colorectal Dis. 2022 Apr;24(4):449-460. doi: 10.1111/codi.16036. Epub 2022 Jan 10. Colorectal Dis. 2022. PMID: 34967100 Free PMC article.
-
Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.Ups J Med Sci. 2012 May;117(2):225-36. doi: 10.3109/03009734.2012.658974. Ups J Med Sci. 2012. PMID: 22512246 Free PMC article.
-
Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulation.Mol Ther Nucleic Acids. 2023 Nov 15;34:102079. doi: 10.1016/j.omtn.2023.102079. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38213952 Free PMC article.
-
Sparing Sphincters and Laparoscopic Resection Improve Survival by Optimizing the Circumferential Resection Margin in Rectal Cancer Patients.Medicine (Baltimore). 2016 Feb;95(5):e2669. doi: 10.1097/MD.0000000000002669. Medicine (Baltimore). 2016. PMID: 26844498 Free PMC article.
-
Overall treatment outcome - analysis of long-term results of rectal cancer treatment on the basis of a new parameter.Arch Med Sci. 2020 Apr 8;16(4):825-833. doi: 10.5114/aoms.2020.94330. eCollection 2020. Arch Med Sci. 2020. PMID: 32542084 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources